The First & Only AI-Based Solution for 2D
Right Ventricle Analysis
Assessing the right ventricle (RV) size and function using ultrasound is a key indicator of cardiac dysfunction including pulmonary embolism, pulmonary hypertension as well as potential heart failure.
Recent studies show that right ventricle dilation in hospitalized COVID-19 patients can be an indicator of high-risk cases. Clinical protocols for COVID-19 recommend assessing its global function.
31% of hospitalized COVID-19 patients had RV dilation and rates of in-hospital mortality were 41% for this subset. Enlarged RV was the predictor of mortality on multivariable analysis.
However, RV analysis is challenging due to the RV’s unique shape and position. Additionally, RV analysis using 2D ultrasound is currently done visually or manually, making the process time-consuming, error-prone and highly dependent on the user’s experience.
LVivo RV provides a fully automated RV size and
function analysis from the 4CH apical view, in one click.
LVivo RV automatically provides:
■ Fractional Area Change (FAC)
■ End Diastolic Area (EDA)
■ End Systolic Area (ESA)
■ Free Wall Strain (FWS)
■ Tricuspid annular plane systolic excursion (TAPSE)
Why LVivo RV ?
Objective & automated
Replaces subjective manual or visual analysis, with accurate and consistent results
Alleviates bottlenecks while reducing scanning time and risk of exposure to COVID-19
Easily added to any ultrasound device and works with any PACS
Easy to use
Results in one click from one view.
No need for M-mode
“The RV has always been very difficult to evaluate, due to its unique structure and location. This is further compounded by the complexity of the analysis itself which relies on a combination of manual calculations and visual user input. LVivo RV is a welcome and very useful addition to clinicians’ toolbox for more quickly and effectively monitoring the right ventricle."
Anthony DeMaria, M.D
Professor of Medicine
Division of Cardiovascular Medicine